June 2025 - Update to the ASRS Questionnaire FAQs

The ASRS questionnaire in Creyos is being shortened from the full 18-question symptom checklist to the core 6-question screener. This change was made at the request of NYU Langone Health, which holds the rights to the full ASRS. The 6-question screener remains scientifically validated and continues to provide reliable insight into attention-related concerns. 

What this means for Creyos users

• The 6-question version will remain fully integrated within Creyos and continue to be supported in your workflows and reporting.
• Any historical data and reports from previously administered 18-question ASRS scales will remain available in your Creyos account.

We’ve put together some Frequently Asked Questions, including the scientific validity, how this impacts ADHD protocol scoring, and your workflows.

Who to contact

Providers who wish to use the full 18-question symptom checklist should contact NYU Langone Health who have requested access be requested by emailing [e-mail]. 

As always, please do not hesitate to reach out to your customer success manager if you have any questions about the ADHD-focused protocol or your Creyos account.